Acute myeloid leukemia (AML) remains one of the most difficult blood cancers to treat. Although drug combinations are often ...

A 27-year-old woman has thanked generous strangers for raising over $133,000 almost overnight so she can undergo potentially ...

For decades, 7+3—consisting of cytarabine plus an anthracycline—has been the backbone of induction therapy for fit adults ...

Tyrosine kinase inhibitors (TKIs) lead to similar outcomes across racial and ethnic groups when used to treat acute myeloid ...

Menin inhibitors reshape AML care, boosting targeted options for KMT2A- and NPM1-mutant disease, with promising frontline ...

Shareholders approve acquisition of Aptose by Hanmi Pharmaceutical in “Go Private” transaction TUS+VEN+AZA triplet frontline therapy continues to ...

The company flagged “potent” preclinical data for its AML drug SLS009 ahead of the AACR 2026 conference. ・CEO Angelos ...

Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...

A Winter Haven family is navigating an emotional and life-changing medical journey, as two young brothers fight the same rare ...

Here, doctors share the number-one sign of leukemia in adults over 50, plus other key symptoms like night sweats, weight loss ...